| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a819eda0adf22936a52362eeebb9fb4 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/H04N13-204 |
| filingDate |
2021-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30fe8e43287af41b4283577832a0c1a1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3bd164d04396085be1dfeb7a601c41e5 |
| publicationDate |
2021-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2021226019-A2 |
| titleOfInvention |
Compositions and methods for treating viral infections |
| abstract |
Provided herein are compositions and methods for treating a coronavirus disease 2019 (COVID-19) caused by a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a subject. The compositions and methods comprise the use of guide RNAs or antisense oligonucleotides (ASOs) that target a portion of the sequence of a SAR-CoV-2 gene in a SAR-CoV-2 genome. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20230074664-A |
| priorityDate |
2020-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |